Yesterday, Hoffmann-La Roche Inc. suspended shipment of Tamiflu® (oseltamivir) in the United States until there is increased incidence of seasonal flu this year, based on concerns that companies and other large entities that do not yet need Tamiflu for this year’s flu virus will hoard it.
There's ample reason for such concern. Back in August, International SOS, a London-based company that provides medical evacuations and other medical and security services to 6,400 corporations, began advising clients such as the Coca-Cola Co., Motorola Inc. and Exxon Mobil Corp. to consider stockpiling Tamiflu in order to protect employees and keep overseas businesses operating during a pandemic.
Now, there's nothing illegal with International SOS providing this advice. What is unacceptable is that for two-plus months, the American government didn't have the vision, the power or the public approach to actively discourage such activities. Nor was there an effort to try to promote any kind of medicinal distribution plan to the public as a real alternative to what organizations such as International SOS was advising.
It is possible - maybe even probable - that the U.S. government "requested" that HLR stop shipment for now to prevent hoarding. But in the case of pandemic, the Bush Administration needs to do more than to stop pre-pandemic hoarding. The government needs to begin the work now to re-educate Americans about the dangers of hoarding during a health emergency, because Americans haven't been in the situation much in the recent past where it has been an issue.


